Our story

• 2010: EXIST-Start-up Grant of the German Ferdral Ministry for Economic Affairs and Energy (BMWI) & the EU-Social Fund.
• 2012: GmbH foundation by an international and experienced team of scientific entrepreneurs as a spin-off from the University of Münster, with investment from well-known German VC investors. 
• 2015: Sybille-Hahne-Entrepreneurship Award (link).
• Cysal transferred natural synthesis of beta-dipeptides from blue-green algae into low cost biotechnological production process using bacterial fermentation and developed their first application market. 
• 2019: out-licensing the developed IP and knowhow to a leading global player in the field of functional ingredients.
• Scale-up of production process to the industrial scale and further development of main application field.
• 2024: aquisition of the technology by the licensee.   

Advanced biotechnological fermentation strategies are increasingly replacing chemical approaches for the production of specialty and base commodities. This trend is set to continue with the increased demand for more sustainable alternatives to traditional industrial processes. 

 Our key interest remains harnessing microbial metabolic diversity not only to develop new own products but also to provide other companies with flexible and affordable services to develop their novel industrial fermentation technologies and products. 

We are committed to sustainable biotechnological solutions that make both ecological and economic sense. Our projects aim to conserve resources and promote environmentally friendly processes. We believe that innovation and sustainability must go hand in hand to create a better future.

Cysal offers services ranging from the optimization and selection of microbial strains for the production of new compounds or activities to the development of complete fermentation and downstream technologies up to the industrial scale. These services are mostly performed in the facility of Cysal and, where required, in facilities of close partners.

Based on its long experience, Cysal offers also consultancy and hands-on

support to biotechnology companies, especially science-to-business startups. Our support extends over the areas of IP, feasibility, outsourcing, regulatory affairs, investors & strategic partners, business contracting & deal structuring.        

Cysal is supported by an established and well-connected network of German and international collaborators in industry and academia. This enables us to support also your validation work required for application in cosmetics, food and feed.